Dr. Kushwaha’s recent scientific article entitled ‘Transforaminal Lumbar Interbody Fusion (TLIF) Augmented with rhBMP-2’ assesses clinical and radiographic outcomes of 77 patients treated with one or two level instrumented transforaminal interbody fusions augmented with interbody recombinent human bone morphogenic protein (rhBMP-2) and allograft for treatment of symptomatic spondylolisthesis or degenerative disc disease.